Board of Directors  
       
 
  Overview
> Board of Directors
  Medical Advisory
  Business Advisory
  Fact Sheet
   

Dr. Gijs Elzinga, Chairman

Following his MD in 1970, and PhD in 1972, he obtained a position in medical physiology at the Free University of Amsterdam, appointed full professor in 1981. In 1991 he became Director Public Health of the National Institute of Public Health and the Environment, where he holds at present a position as deputy Director-General. From 1993 onwards he was increasingly engaged in global TB control. Till 1998 Dr. Elzinga was Chair of the Co-ordinating, Advisory and Review Group that guided the Global TB Program of the WHO. In 2000 he was elected member of the board of the Global Alliance for TB drug development, becoming Chair thereof in 2004. When in 2000 the Stop TB Partnership was formed he was approached to chair the TB/HIV working group, re-elected in that position in 2004 for a second term till 2007. He is one of the co-chairs of the Joint Learning Initiative of the RF, which identified limitations of the health workforce as the major obstacle in the delivery of health to populations of developing countries.

 

Jaap F. Broekmans, Secretary

Dr Jaap F. Broekmans is Executive Director of KNCV Tuberculosis Foundation in The Hague , The Netherlands. KNCV Tuberculosis Foundation is a leading technical agency in the implementation of modern tuberculosis control strategies in countries in Asia, Africa, Latin America and Eastern Europe . Dr Broekmans has played a major role in developing the DOTS strategy in Tanzania , Vietnam , China and Indonesia . He is a founding member of the Stop TB Partnership. He served as chairman of the WHO Strategic Technical Advisory Group on Tuberculosis (STAG-TB) and serves as chairman of the Board of the Tuberculosis Coalition for Technical Assistance (TBCTA), a USAID funded collaboration of KNCV Tuberculosis Foundation, Centers for Disease Control and Prevention, World Health Organization, International Union Against Tuberculosis and Lung Disease, American Long Association and American Thoracic Society.

 

Dominic Montagu, MBA, DrPH, President, CEO and Treasurer

Mr. Montagu is an Assistant Professor of Epidemiology and Biostatistics at UCSF, working in the Institute for Global Health, and a visiting Assistant Professor at the UCBerkeley School of Public Health. Dr. Montagu received his doctoral and masters degrees from Berkeley , following undergraduate studies at MIT.

During much of the 1990s Mr. Montagu worked in Vietnam , including two years as Country Director of the American Friends Service Committee, and a year as a researcher and Country Advisory at the Population Council. Mr. Montagu has worked as a consultant for the World Bank, WHO, DfID, and a number of other organizations. His specialization in private sector health began during his time with the Population Council in Hanoi , and was strengthened during an internship at the Packard Foundation's Population program. He has focused specifically on franchise systems and other quality control options for managing private sector integration into public health goals, and has a number of publications in this field.

 

Ariel Pablos-Mendez, MD

Dr. Pablos-Mendez is a Mexican physician and epidemiologist, is an Associate Professor of Clinical Medicine and Public Health at Columbia University in New York . Dr. Pablos-Mendez worked on the emergence of multi-drug resistant tuberculosis in New York City in 1991 and, in 1997, led the Global Surveillance Project on Anti-Tuberculosis Drug Resistance. In both instances, this research brought about significant policy changes. Starting in 1998, he spearheaded the program “Harnessing the New Sciences” at The Rockefeller Foundation, targeting product development for orphan diseases through public-private partnerships. In 2000, working with other international agencies and donors, Ariel's vision and leadership drove the creation of the Global Alliance for TB Drug Development to shorten and facilitate the treatment of the disease in poor countries. He also led a rethinking of the Rockefeller Foundation's program in AIDS, which brought about a new AIDS care research initiative in Africa and contributed to a program for the treatment of mothers with AIDS and their families (MTCT-Plus) in 2001. In 2002, Ariel championed the creation of an international Center for the Management of IPR in Health R&D (MIHR) and in 2003 fostered a Joint Learning Initiative on Human Resources for Health and Development. He was elected to the American Society of Clinical Investigation in 2003, and serves in various Boards and Advisory Committees. After serving as Deputy and Acting Director of the Health Program at the Rockefeller Foundation, Ariel moved to Geneva in May 2004 as Director of Knowledge Management and Sharing at the World Health Organization.

 

Khama Rogo, MD, PhD

Trained as an obstetrician-gynecologist, Dr. Rogo later earned his MD/PhD in Gynecologic Oncology from Umea University , Sweden . Dr. Rogo served as the Vice President for Africa for Ipas from 1998-2001.

Dr. Rogo has served as a consultant to the UN/WHO, UNFPA, UNICEF, USAID, and DFID, as well as many other international organizations. He has also been President of the Kenya Medical Association and Chairman of Kenya's National Council on Population and Development, and Chairman of the Centre for the Study of Adolescence in Nairobi . Dr Rogo is the Founder of K-MET, an extensive network of private providers of high quality, comprehensive reproductive health care in Africa and winner of the Margaret Sanger Award in 2004.

Dr. Rogo currently serves as the Lead Health sector Specialist and Advisor for Population and Reproductive Health at The World Bank. In that capacity, he leads work on population and reproductive health for the Africa Region, the Bank's work in Safe Motherhood, and institutional linkage with WHO/HRP. Dr Rogo serves in the Advisory Boards of The Packard Foundation, PATH, INTRAH and The Center for African Family Studies (CAFS). He has previously served in the board of RPMMN and was a founder member of WHO's Gender Advisory Group. Dr. Rogo is widely published and continues to pursue his interest in academics through numerous appointments, affiliations, lectures and supervision of postgraduate students in Universities in Africa, Europe and North America .

 

Eric van Praag, MD, MPH

Eric van Praag has nearly 30 years of clinical, epidemiological and public health experience around the world. He currently is the country director for FHI's HIV/AIDS Institute in Tanzania assisting the Ministry of Health and several public and NGO health facilities to implement HIV care and treatment. Until recently he served as Director of the Care, Treatment and Support Division at FHI's HIV/AIDS Institute, where he managed the HIV/AIDS care projects, ensuring the appropriate application of clinical and public health theories and field experiences to the design and implementation of comprehensive HIV care interventions including the introduction of antiretroviral therapies and reinforcement of prevention as well. Dr. van Praag and his Division recently completed various case studies on district based HIV capacity needs in health facilities in Zambia , Tanzania , Kenya , Ethiopia and Cambodia and introduced comprehensive HIV care with antiretroviral therapy in Ghana , Rwanda and Kenya . Prior to joining FHI, Dr. van Praag served as Acting Director of the HIV/AIDS and STD Initiative for the World Health Organization, where he also held coordination positions in HIV programming, epidemiology and care since 1991. From 1988-1991 he was the WHO-GPA Team leader supporting the Government of Zambia to start up their HIV Prevention, Care and Mitigation Programme. Before 1988, he has held public health positions at the Royal Tropical Institute in The Netherlands and with the Ministry of Public Health in Bangladesh as a bilateral expert through the Netherlands Ministry of Foreign Affairs. His first experience with tropical public health was in Tanzania from 1974-1982 at various mission, government and teaching hospitals being a senior lecturer Community Health at the University of Dar es Salaam from 1977-1982.

 
       
       
       

74 New Montgomery, Suite 508, San Francisco, California 94105-3411, USA

Tel: +1.415.597.9326 Fax: +1.415.597.8299 Email: info@healthspotfranchise.org